Skip to main content
Bioceltix S.A. logo

Bioceltix S.A. — Investor Relations & Filings

Ticker · BCX ISIN · PLBCLTX00019 LEI · 259400QZD5JYK8SLZU51 WAR Manufacturing
Open in API
Filings indexed 270 across all filing types
Latest filing 2023-03-21 Capital/Financing Update
Country PL Poland
Listing WAR BCX

About Bioceltix S.A.

https://bioceltix.com/en/

Bioceltix S.A. is a biopharmaceutical company that develops stem cell-based medicinal products for veterinary use. The company focuses on creating therapies that utilize Mesenchymal Stem Cells (MSCs) as the active pharmaceutical ingredient. Its product pipeline is aimed at treating immunological and inflammatory conditions in companion animals, including dogs, cats, and horses. A key area of development includes treatments for conditions such as atopic dermatitis in dogs and degenerative joint disease.

Recent filings

Filing Released Lang Actions
Zakończenie procesu ABB. Ustalenie ostatecznej liczby oraz ceny oferowanych akcji. - Content (PL)
Capital/Financing Update Classification · 1% confidence The document text, written in Polish, discusses the finalization of an accelerated book-building process ('przyspieszonej budowy księgi popytu' or ABB) for newly issued shares (Series K) and shares being sold by an existing shareholder (Kvarko Group). It explicitly sets the final number of shares (400,000 new, 150,000 sold) and the final issue/sale price (37.00 PLN). This activity directly relates to fundraising, capital structure changes, and the issuance/sale of shares. This aligns best with the 'Capital/Financing Update' (CAP) or potentially 'Share Issue/Capital Change' (SHA). Since the core action is setting the terms for a capital raise/offering, CAP is the most precise fit, as it covers fundraising activities. The document is a formal announcement detailing the outcome of a financing event.
2023-03-21 Polish
Zawarcie aneksów do umów lock-up przez istotnych akcjonariuszy Emitenta - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document text, written in Polish, discusses amendments ('aneksy') to existing lock-up agreements ('umów o ograniczeniu rozporządzania akcjami' or 'umów typu lock-up') concerning the shares of several major shareholders (Infini ASI, Kvarko Group ASI, Alternative Solution ASI, and Łukasz Bzdzion). These agreements restrict the ability of these parties to sell ('zbywania') their shares for specified periods. This type of announcement details restrictions or changes related to the ownership and trading of company shares by insiders or major holders. This aligns best with the category covering changes in significant share ownership levels or restrictions on trading, which is Major Shareholding Notification (MRQ). It is not a standard financial report (10-K, IR), an earnings release (ER), or a director's dealing report (DIRS), as it focuses on contractual restrictions on existing large shareholders rather than a single transaction by a director or a general financial result.
2023-03-20 Polish
Zmiana terminu publikacji raportu rocznego za 2022 rok - Content (PL)
Report Publication Announcement Classification · 1% confidence The document text is very short (357 characters) and explicitly states that the company ('Spółka') is informing about a change in the date for the publication of its annual report for 2022 ('raportu rocznego za 2022 rok'). This is an announcement about the timing of a future report release, not the report itself. According to Rule #2 (The 'Menu vs Meal' Rule), a short announcement regarding the publication timing of a report should be classified as a Report Publication Announcement (RPA). The original report would likely be a 10-K, but this document is the announcement of its release date change.
2023-03-17 Polish
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na NWZA Bioceltix S.A., które odbyło się 13 marca 2023 roku - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document text is in Polish and details the list of shareholders who held at least 5% of the votes at an Extraordinary General Meeting of Shareholders ('Nadzywczajne Walne Zgromadzenie Akcjonariuszy' or NWZA) held on March 13, 2023. It explicitly lists the number of votes and percentage holdings for three major shareholders. This content directly relates to the official results of a shareholder vote at a general meeting. Therefore, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document is short and contains the results directly, not an announcement about the results.
2023-03-14 Polish
Treść uchwał podjętych przez NWZA w dniu 13 marca 2023 roku
AGM Information Classification · 1% confidence The document text consists of multiple resolutions ('Uchwała nr...') passed by the 'Nadzwyczajne Walne Zgromadzenie' (Extraordinary General Meeting) of the company BIOCELTIX S.A. on March 13, 2023. These resolutions cover procedural matters (electing a chairman, adopting the agenda) and substantive decisions, most notably the resolution to increase share capital ('podwyższenia kapitału zakładowego') by issuing new Series K shares, and a resolution to amend the company's articles of association ('zmiany statutu') to grant the Management Board authority regarding a target capital increase ('kapitału docelowego'). Documents detailing the resolutions and voting outcomes of a General Meeting, especially when they involve significant corporate actions like capital changes, are typically classified as AGM-related materials or regulatory filings detailing the meeting's outcome. Since the document explicitly details the content of the resolutions passed at the EGM, it strongly aligns with the purpose of documenting the meeting's proceedings. While it contains elements of capital changes (CAP), the primary context is the meeting itself. Given the content is the direct output of the meeting, 'AGM-R' (AGM Information) is the most appropriate classification, as it details the decisions made during the meeting.
2023-03-14 Polish
Uchwały podjęte przez NWZA w dniu 13 marca 2023 roku - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document text is very short (635 characters) and explicitly states that it conveys the content of resolutions ('treść uchwał') passed during an Extraordinary General Meeting ('Nadzwyczajnego Walnego Zgromadzenia') held on March 13, 2023, and mentions that the content of the resolutions is in an attachment ('Treść uchwał znajduje się w załączniku do raportu'). This structure—announcing the results of a shareholder vote and referencing an attachment—strongly suggests a formal declaration of voting results from a general meeting. This aligns best with the Declaration of Voting Results & Voting Rights Announcements (DVA) definition. It is not the AGM presentation itself (AGM-R), nor is it a general announcement about a report being published (RPA), as it contains the core information about the vote outcomes.
2023-03-14 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.